Closer Monitoring Recommended for Older Patients Treated With Dolutegravir for HIV
The maximum concentration of the integrase inhibitor dolutegravir was significantly higher in older people living with HIV.
For children receiving , HIV-1-specific antibody levels can be useful markers for measuring viral suppression or for low residual cell-associated HIV-1 DNA levels.
For criminal justice-involved persons living with HIV, sustained retention in care decreases over time post-release.
A flexible, scalable intervention increases antiretroviral therapy and medication-assisted treatment use while reducing mortality in people who inject drugs.